Search all trials

Find therapies in clinical trials near you – page 830

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 955
countries: 28
conditions: 2 101

3 955 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Diabetic retinopathy

Not recruiting

Investigational

Study on BI 764524 for Patients with Moderate to Severe Diabetic Retinopathy

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Bi 764524

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Registered drugNo placebo

Study on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Belimumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Rectal cancer

Not recruiting

Registered drugNo placebo

Study Comparing Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin to Standard Treatment for Patients with Locally Advanced Rectal Cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Pancreatic carcinoma+1

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of Nivolumab, Ipilimumab, Gemcitabine, and Paclitaxel for Patients with Advanced Pancreatic Cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study on the Safety and Tolerability of Olaparib in Children and Adolescents with Solid Tumors

Registered drugNo placebo

Denmark

Participants:0–17 years
Substances:Olaparib

Contact Research Centre

Psychotic disorder

Not recruiting

Registered drug

Study of Cannabidiol and Risperidone for Treatment of Non-Affective Psychosis in Patients with History of Cannabis Use

Registered drug

Denmark

Participants:18–64 years
Substances:Cannabidiol

Contact Research Centre

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of Asciminib Treatment for Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Asciminib Hydrochloride

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study on Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Malignant melanoma+1

Not recruiting

Registered drugNo placebo

Study of 89Zirconium-labeled ipilimumab distribution in patients with metastatic melanoma receiving ipilimumab/nivolumab combination therapy

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:Ipilimumab

Contact Research Centre

Prostate cancer

Not recruiting

Registered drugNo placebo

Study of enzalutamide compared to bicalutamide and flutamide in first-line treatment for patients with metastatic prostate cancer

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Bicalutamide

Contact Research Centre

Find therapies in clinical trials near you – page 830

10 242 trials match your criteria

Non-small cell lung cancer

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Diabetic retinopathy

Study on BI 764524 for Patients with Moderate to Severe Diabetic Retinopathy

Systemic lupus erythematosus

Study on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus

Non-small cell lung cancer

Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

Rectal cancer

Study Comparing Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin to Standard Treatment for Patients with Locally Advanced Rectal Cancer

Pancreatic carcinoma+1

Study on the Safety and Effects of Nivolumab, Ipilimumab, Gemcitabine, and Paclitaxel for Patients with Advanced Pancreatic Cancer

Neoplasm

Study on the Safety and Tolerability of Olaparib in Children and Adolescents with Solid Tumors

Psychotic disorder

Study of Cannabidiol and Risperidone for Treatment of Non-Affective Psychosis in Patients with History of Cannabis Use

Chronic myeloid leukaemia

Study of Asciminib Treatment for Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase

Hepatocellular carcinoma

Study on Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

Malignant melanoma+1

Study of 89Zirconium-labeled ipilimumab distribution in patients with metastatic melanoma receiving ipilimumab/nivolumab combination therapy

Prostate cancer

Study of enzalutamide compared to bicalutamide and flutamide in first-line treatment for patients with metastatic prostate cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.